These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26489545)

  • 21. Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study.
    Kirchheiner K; Nout RA; Czajka-Pepl A; Ponocny-Seliger E; Sturdza AE; Dimopoulos JC; Dörr W; Pötter R
    Gynecol Oncol; 2015 Mar; 136(3):415-23. PubMed ID: 25462202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
    Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW
    Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience.
    Tharavichitkul E; Chakrabandhu S; Wanwilairat S; Tippanya D; Nobnop W; Pukanhaphan N; Galalae RM; Chitapanarux I
    Gynecol Oncol; 2013 Jul; 130(1):81-5. PubMed ID: 23603369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.
    Schwarz JK; Wahab S; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1258-63. PubMed ID: 20932657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.
    Zhu ZF; Ma HL; Fan M; Bao Y; Zhuang TT; Chen M; Jiang GL; Fu XL
    Technol Cancer Res Treat; 2014 Jun; 13(3):269-75. PubMed ID: 24066952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation.
    Kim TE; Park BJ; Kwack HS; Kwon JY; Kim JH; Yoon SC
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1315-20. PubMed ID: 22612778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Du XL; Tao J; Sheng XG; Lu CH; Yu H; Wang C; Song QQ; Li QS; Pan CX
    Gynecol Oncol; 2012 Apr; 125(1):151-7. PubMed ID: 22198339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
    Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
    Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
    Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity.
    Xu J; He X; Cheng K; Guo W; Bian X; Jiang X; Zhang L; Huang S
    Head Neck; 2014 Oct; 36(10):1474-80. PubMed ID: 23996842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
    Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
    Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Nodal Disease in Advanced Cervical Cancer.
    Jürgenliemk-Schulz IM; Beriwal S; de Leeuw AAC; Lindegaard JC; Nomden CN; Pötter R; Tanderup K; Viswanathan AN; Erickson B
    Semin Radiat Oncol; 2019 Apr; 29(2):158-165. PubMed ID: 30827454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer.
    Takeshita S; Kita T; Motoike Y; Umezawa K; Sugisaki S; Matsumoto S; Matsumoto Y; Ryo E; Ayabe T
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1009-14. PubMed ID: 20722988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
    Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concurrent chemoradiotherapy (CCRT) in uterine cervical cancer].
    Toita T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():255-9. PubMed ID: 23156252
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in east and southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Cao J; Xu X; Devi CR; Swee TT; Calaguas MJ; de Los Reyes RH; Cho CK; Dung TA; Supriana N; Erawati D; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):100-5. PubMed ID: 23920390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
    Gao K; Ding L; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.